| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 33.90 mm | 33.90 mm | 33.90 mm | 33.90 mm | 33.90 mm | 33.90 mm |
| Cash burn (monthly) | 98.63 mm | 2.39 mm | 9.97 mm | 6.37 mm | (no burn) | 802.83 k |
| Cash used (since last report) | 276.26 mm | 6.71 mm | 27.92 mm | 17.85 mm | n/a | 2.25 mm |
| Cash remaining | -242.36 mm | 27.19 mm | 5.98 mm | 16.05 mm | n/a | 31.65 mm |
| Runway (months of cash) | -2.5 | 11.4 | 0.6 | 2.5 | n/a | 39.4 |
| 13F holders | Current |
|---|---|
| Total holders | 95 |
| Opened positions | 25 |
| Closed positions | 8 |
| Increased positions | 32 |
| Reduced positions | 21 |
| 13F shares | Current |
|---|---|
| Total value | 856.53 bn |
| Total shares | 35.41 mm |
| Total puts | 400.00 |
| Total calls | 400.00 |
| Total put/call ratio | 1.0 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 4.40 mm | $120.56 bn |
| Bain Capital Life Sciences Investors | 3.01 mm | $82.51 bn |
| Avidity Partners Management | 2.92 mm | $79.87 bn |
| Fairmount Funds Management | 2.70 mm | $73.94 bn |
| Ra Capital Management | 2.33 mm | $63.88 bn |
| Octagon Capital Advisors | 1.75 mm | $47.82 bn |
| VR Adviser | 1.74 mm | $47.76 bn |
| Venrock Healthcare Capital Partners III | 1.74 mm | $48.77 mm |
| BlackRock | 1.64 mm | $45.04 bn |
| Vanguard | 1.29 mm | $35.46 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Sep 24 | Fairmount Funds Management | Common Stock | Other | Dispose J | Yes | No | 0 | 62,146 | 0.00 | 0 |
| 16 Sep 24 | Romano Steven J. | Stock Option Common Stock | Grant | Acquire A | No | No | 26.42 | 22,000 | 581.24 k | 22,000 |
| 23 May 24 | Marino Garcia | Stock Option Common Stock | Grant | Acquire A | No | No | 21.77 | 243,000 | 5.29 mm | 243,000 |
| 23 May 24 | Simrat Randhawa | Stock Option Common Stock | Grant | Acquire A | No | No | 21.77 | 100,000 | 2.18 mm | 100,000 |
